Original Source(s)
Related Content
FDA approves first therapy for Alexander disease
The antisense oligonucleotide reduces production of the abnormal protein that accumulates in supportive cells in the brain.
September 4, 2026
-
2 min
PMOS-dementia link may reflect metabolic risks
Investigators identify insulin resistance and obesity as possible contributors to neurologic changes.
October 21, 2026
-
4 min